Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/12/2026 | Q4 | -- | -- | -- | -$1.60 | -- |
| 11/05/2025 | Q3 | $5.9M | $351K | $0.94 | $1.28 | -$0.34 |
| 08/06/2025 | Q2 | -- | -- | -$2.27 | -$2.28 | $0.00 |
| 05/07/2025 | Q1 | $10M | -- | $3.75 | $1.97 | $1.78 |
| 03/13/2025 | Q4 | -- | -- | -$1.81 | -$3.99 | $2.18 |
| 11/13/2024 | Q3 | $25.8M | -- | -$0.38 | -$0.04 | -$0.34 |
| 08/13/2024 | Q2 | -- | -- | -$4.34 | -$5.91 | $1.57 |
| 05/08/2024 | Q1 | $250K | -- | -$5.49 | -$7.25 | $1.76 |
| 03/05/2024 | Q4 | -$180.8K | -- | -$6.38 | -$11.36 | $4.97 |
| 11/02/2023 | Q3 | -- | -- | -$7.46 | -- | -- |
| 08/08/2023 | Q2 | -- | $126.5M | $0.36 | -- | -- |
| 05/09/2023 | Q1 | -- | -$522K | -$0.57 | -- | -- |
| 03/07/2023 | Q4 | -- | $975K | -$0.55 | -- | -- |
| 11/02/2022 | Q3 | -- | $3.4M | -$0.49 | -- | -- |
| 08/03/2022 | Q2 | -- | $1.2M | -$0.70 | -- | -- |
| 05/04/2022 | Q1 | -- | $1.5M | -$0.61 | -- | -- |
| 03/01/2022 | Q4 | -- | $7.2M | -$0.54 | -- | -- |
| 11/10/2021 | Q3 | -- | $126.7M | $0.72 | -- | -- |
| 08/03/2021 | Q2 | -- | $5.3M | -$0.53 | -- | -- |
| 05/04/2021 | Q1 | -- | $5.7M | -$0.39 | -- | -- |
| 03/02/2021 | Q4 | -- | $17.6M | -$0.20 | -- | -- |
| 11/09/2020 | Q3 | -- | $1.4M | -$0.36 | -- | -- |
| 07/28/2020 | Q2 | -- | $6M | -$0.28 | -- | -- |
| 05/07/2020 | Q1 | -- | $8.2M | -$0.28 | -- | -- |
| 03/02/2020 | Q4 | -- | $7.6M | -$0.27 | -- | -- |
| 11/05/2019 | Q3 | -- | $7M | -$0.23 | -- | -- |
| 08/06/2019 | Q2 | -- | $12.5M | -$0.24 | -- | -- |
| 05/02/2019 | Q1 | -- | $7.3M | -$0.59 | -- | -- |
| 03/06/2019 | Q4 | -- | $10.6M | -$0.52 | -- | -- |
| 11/08/2018 | Q3 | -- | $9.1M | -$0.54 | -- | -- |
| 08/02/2018 | Q2 | -- | $4.6M | -$0.68 | -- | -- |
| 05/09/2018 | Q1 | -- | $4M | -$0.69 | -- | -- |
| 03/08/2018 | Q4 | -- | $3.1M | -$0.71 | -- | -- |
| 11/08/2017 | Q3 | -- | $23M | -$0.17 | -- | -- |
| 08/03/2017 | Q2 | -- | $3M | -$13.80 | -- | -- |
| 03/31/2017 | Q1 | -- | $3M | -$0.63 | -- | -- |
| 03/16/2017 | Q4 | -- | $3M | -$0.63 | -- | -- |
| 09/30/2016 | Q3 | -- | $13M | -$0.46 | -- | -- |
| 06/30/2016 | Q2 | -- | $3M | -$0.70 | -- | -- |
| 03/31/2016 | Q1 | -- | $2.7M | -$0.50 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$0.50 | -- | -- |
Seres Therapeutics, Inc. reported $351K worth of top line sales in its most recent quarter.
Seres Therapeutics, Inc. announced earnings per share of $0.94 which represents a miss of analyst forecast a $1.28 per share.
Seres Therapeutics, Inc. reported -$693K that represents -$0.08 per share over the last quarter.
Seres Therapeutics, Inc.'s earnings are forecast to decrease from -$18.86 per share to -$8.17 per share next year representing a decrease of -75.83%.
Seres Therapeutics, Inc.'s next earnings date is March 12, 2026.
Signup to receive the latest stock alerts
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Market Cap: $4.5T
P/E Ratio: 63x
Market Cap: $4T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
UniFirst Corp. [UNF] is up 0.77% over the past day.